(UroToday.com) The 2026 North Central Section of the AUA annual meeting featured a prostate cancer session and a presentation ...
The 2026 North Central Section of the AUA annual meeting featured a urothelial carcinoma session and a presentation by Dr.
To evaluate the hypothesis that infectious adverse events following prostatic artery embolization (PAE) are comparable to those following other treatment options for benign prostatic hyperplasia (BPH) ...
Daniel Spratt and Alicia Morgans discuss clinical outcomes of patients with Gleason score 9-10 prostate cancer after definitive treatment. Long-term Survival in Men with Gleason Score 9-10 Treated ...
Advanced prostate cancer is one of the leading causes of cancer mortality in men and is often characterized by disease progression through therapeutic evasion followed by metastasis. Emerging evidence ...
Precision oncology relies on integrating tumour fraction, variant allele frequency, clonal haematopoiesis of indeterminate potential assessment, pathogenicity, and clinical context into ...
Current clinical risk stratification for determining neoadjuvant chemotherapy (NAC) usage in nonmetastatic upper tract urothelial carcinoma (UTUC) is frequently inaccurate. This uncertainty leads to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results